Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.
Pelland AA, Deschênes-Simard X, Savard X, Giguère P, Spillane D, Barabé F, Laroche V, Munger M, Gallagher G, Marcoux N, Cantin G, Chénard-Poirier M, Delage R, Lalancette M, Veilleux O, Assouline SE, Lemieux C.
Pelland AA, et al. Among authors: munger m.
Leuk Lymphoma. 2024 Dec;65(13):1974-1982. doi: 10.1080/10428194.2024.2390574. Epub 2024 Aug 11.
Leuk Lymphoma. 2024.
PMID: 39129334